Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 7, 2011; 17(41): 4602-4606
Published online Nov 7, 2011. doi: 10.3748/wjg.v17.i41.4602
Table 1 Clinical characteristics of patients
LGS (n = 22)OGS (n = 25)P value
Median age, yr (range)67 (38-75)68 (54-75)0.07
Gender (M/F)13/913/120.4
BMI, kg/m2 (range)23 (18-25)22 (18-26)0.9
ASA score, median (range)2 (0-3)2 (0-3)0.3
05 (23%)2 (8%)
13 (14%)8 (32%)
210 (45%)10 (40%)
34 (18%)5 (20%)
Tumor location (%)0.9
Upper5 (23%)6 (24%)
Middle7 (32%)7 (28%)
Lower10 (45%)12 (48%)
Lauren histology (%)0.7
Intestinal12 (54%)12 (48%)
Diffuse10 (46%)13 (52%)
pTNM [1997] (%)0.6
Ib2 (9%)2 (8%)
II9 (41%)13 (52%)
IIIa/b10 (45%)7 (28%)
IV1 (5%)3 (12%)
Table 2 Operative findings
LGS (n = 22)OGS (n = 25)P value
Type of gastric resection (%)0.7
Subtotal17 (77%)18 (72%)
Total5 (23%)7 (28%)
Reconstruction (%)0.6
Billroth 23 (14%)2 (8%)
Roux-en-Y19 (86%)23 (92%)
Lymphadenectomy (%)1
D12 (9%)2 (8%)
D220 (91%)23 (92%)
Lymph-nodes retrived29 ± 730 ± 90.5
Table 3 Tumour recurrence and survival analyses
LGS(n = 22)OGS(n = 25)P value
Overall 5 yr mortality rate12 (54.5%)14 (56%)1
Cancer-related 5 yr mortality rate11 (50%)13 (52%)1
FU (5 yr) accomplishment20 (91%)23 (92%)1
Type of recurrence0.9
Port-site M0 (0%)
Locoregional/carcinosis2 (18%)4 (31%)
Hepatic M6 (55%)6 (46%)
Distant M3 (27%)3 (23%)
Median survival, mo (range)39 (12-60)38 (11-60)0.7
Disease free interval, mo (range)28 (12-60)26 (10-60)0.6
Table 4 Survival analyses by Kaplan-Meier method
AGC + T1b (n = 47)AGC (n = 43)
Cancer related survival probability analyses (P)0.810.92
Overall survival probability analyses (P)0.830.92